X
Email:
sales@ruixibiotech.com

AT-56,cas:162640-98-4

1-[4-(2H-tetrazol-5-yl)butyl]-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine

Catalog # Pkg Size Price(USD) Quantity Buy this product
R-XASYS-00709 50mg 458.00
- +
+ Add to cart
R-XASYS-00709 100mg 779.00
- +
+ Add to cart

Product description

AT-56(C25H27N5,397.52) is a potent, selective and orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS), with an IC50 of 95 μM and Ki of 75 μM. AT-56 could selectively suppress the drowsiness or pain reaction mediated by L-PGDS-catalyzed PGD2.

AT-56,cas:162640-98-4

Appearance N/A
Molecular Weight N/A
Purity >90%
Solubility N/A
Storage -20℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 3 weeks
Stability 1 year
Document

Related Product